Dwight H Egan's most recent trade in Co-Diagnostics Inc was a trade of 163,334 Common Stock done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 163,334 | 686,191 (2%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 163,334 | 300,833 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.24 per share. | 23 May 2025 | 51,697 | 634,494 (2%) | 0% | 0.2 | 12,407 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2024 | 163,333 | 464,167 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2024 | 163,333 | 572,547 (2%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 1.01 per share. | 23 Nov 2024 | 49,689 | 522,858 (2%) | 0% | 1.0 | 50,186 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 138,333 | 409,214 (1%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 138,333 | 627,500 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 1.09 per share. | 23 May 2024 | 42,008 | 367,206 (1%) | 0% | 1.1 | 45,789 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 275,000 | 765,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 105,000 | 198,197 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 105,000 | 641,667 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 1.32 per share. | 23 May 2023 | 32,103 | 166,094 (0%) | 0% | 1.3 | 42,376 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 275,000 | 746,667 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 155,000 | 471,667 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 79,166 | 316,667 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 79,166 | 125,307 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 3.47 per share. | 23 Nov 2022 | 32,110 | 93,197 (0%) | 0% | 3.5 | 111,422 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 275,000 | 395,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 33,334 | 120,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 33,334 | 57,995 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 4.99 per share. | 23 May 2022 | 11,854 | 46,141 (0%) | 0% | 5.0 | 59,151 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 33,333 | 154,167 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2021 | 33,333 | 40,205 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 23 Nov 2021 | 15,544 | 24,661 (0%) | 0% | 8.4 | 131,191 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 125,000 | 187,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 12,500 | 12,500 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 12,500 | 62,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.90 per share. | 24 May 2021 | 5,628 | 6,872 (0%) | 0% | 7.9 | 44,459 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 50,000 | 50,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 15 Jan 2021 | 50,000 | 50,000 (0%) | 0% | 2.6 | 131,500 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 15 Jan 2021 | 38,046 | 0 (0%) | 0% | 11 | 418,506 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. | 15 Jan 2021 | 11,954 | 38,046 (0%) | 0% | 2.6 | 31,439 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 80,000 | 50,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 20 Nov 2020 | 80,000 | 80,000 (0%) | 0% | 1.1 | 88,000 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.44 per share. | 20 Nov 2020 | 71,569 | 0 (0%) | 0% | 10.4 | 747,180 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 20 Nov 2020 | 50,000 | 50,000 (0%) | 0% | 1.1 | 55,000 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 50,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.51 per share. | 20 Nov 2020 | 44,764 | 0 (0%) | 0% | 10.5 | 470,470 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 20,000 | 130,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 20 Nov 2020 | 20,000 | 20,000 (0%) | 0% | 1.1 | 22,000 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.09 per share. | 20 Nov 2020 | 18,017 | 0 (0%) | 0% | 11.1 | 199,809 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 20 Nov 2020 | 8,431 | 71,569 (0%) | 0% | 1.1 | 9,274 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 20 Nov 2020 | 5,236 | 44,764 (0%) | 0% | 1.1 | 5,760 | Common Stock |
| Co-Diagnostics Inc | Dwight H Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 20 Nov 2020 | 1,983 | 18,017 (0%) | 0% | 1.1 | 2,181 | Common Stock |